In 1956 Boller' observed that patients with ulcerative colitis (UC) smoked considerably less than patients with peptic ulcer disease. In 1976 Samuelsson2 found that patients with UC significantly more often were non-smokers than matched controls from the general population. Samuelsson considered this to be an effect of the disease, however, and not of aetiologic importance. His observation passed unnoticed until Harries et al3 made the same finding which was confirmed by Jick and Walker4 who also found that smoking might reduce the risk of acquiring UC in a dose dependent way. These studies concerned current habits at the time of the investigation and not the smoking pattern at the time of diagnosis or disease onset, which is more important from an aetiologic point of view. This has later been studied by others56 and the dominance of non-smokers in patients with UC was evident also as a pre-illness feature. After a discussion in the British Medical Journal, Logan and Langman7 recalculated their and others results which fairly strongly indicated that exsmokers suffered an increased risk to develop UC.
This finding is possibly supported by a recent study6 which also showed a reduced risk of acquiring UC in heavy smokers. Only one study5 has used fairly adequate control subjects while the others`46 used other hospital patients as controls which must be considered less appropriate as earlier studies have indicated that hospital controls smoke more than population controls.' , The use of inadequate controls might be the reason why the first studies of smoking habits in patients with Crohn's disease (CD) did not show any differences in comparison with the control group. 5' Later two other studies6' showed that patients with CD tended to be smokers to a much higher degree than controls. Only one of them '2 used Although we have no hard data on the patient's delay before seeking medical advice, however, we know that in the great majority of patients with IBD in Sweden it is very short at present, and that the doctor's delay until diagnosis of these cases is also very short. Furthermore the questionnaires contained questions about earlier and present gastrointestinal complaints so we believe that no control subject had overt IBD.
ANALYSIS
The patients and controls were divided into moderate smokers, if they regularly consumed up to 10 cigarettes per day and heavy smokers if they smoked 11 or more cigarettes per day. As few people in Sweden smoke more than 20 cigarettes per day it was not considered meaningful to divide the smokers into further subgroups. Pipe smokers and cigar smokers were excluded from subgrouping as their way of smoking is different from cigarette smokers. As they definitely are or have been exposed to tobacco smoke, however, they were included in the smoking or exsmoking groups when calculating the relative risks.
All subjects who had answered the questionnaire were included in the unmatched analysis while the matched analysis only concerned patients where both or one of their controls had replied. The statistical analyses were performed using multiple logistic regression techniques while controlling for potential confounding variables (sex, age and residence), as described by Breslow and Day.'6 The relative risks for both matched and unmatched designs were calculated. Although similar risk estimates were obtained independently of which design was used the results regarding both matched and unmatched materials are presented. Table 2 and Table 3 shows the years of diagnosis. Table 5 .
CROHN'S DISEASE
In the CD group, Table 6 , the number of smokers at the time of diagnosis was significantly higher (56&3%) Table 5 . Between the time of diagnosis and the survey some of the patients and the controls had given up smoking, so that at the survey the percentages of smokers were 53.5 and 34.7 respectively. Thus in the two control groups the proportion of non-smoking subjects was very similar at the time of the survey.
Discussion
When doing a case control study the choice of controls is essential. Patients with other diseases are less appropriate as control subjects in a study concerning smoking.9 Only three other studies regarding IBD and smoking have used controls from the general population.2512 One of these concerned the habits at the time of survey, however, and not the time of diagnosis or onset of symptoms.2 Of the two others one has dealt with UC5 and the other with CD.'2 Ideally the habit at the onset of symptoms should be analysed in order to get adequate information for aetiologic considerations. This is difficult to define in all patients with IBD, however, while the time of diagnosis is certain. As mentioned earlier under Methods the time period between onset of symptoms and diagnosis is short in the majority of cases.
As almost all patients with IBD residing within the catchment area of our hospital are referred to us a study of incident instead of prevalent cases would have shown similar results if the recall bias regarding smoking habits is minimal. In our experience smokers and exsmokers are well aware of the time when they started smoking and perhaps even better regarding the date they finished if they are exsmokers. They also very well know the amount of daily tobacco consumption. Thus, the risk of recall bias in this respect is small.
When analysing our control material from different aspects two things deviated from the findings in the patient groups. One was the smoking habits and the other the marital status. In contrast with the findings by Keighley et al,'7 a larger number of women with CD in our series had always lived alone compared with their controls. This must be subject for further studies.
In the present study we have confirmed the earlier reports that smoking reduces the risk of acquiring UC in a dose dependent way.47 The non-smoking characteristics in UC was evident but this was an effect of a larger number of exsmokers in the UC than the control group as the percentage of never-smokers was the same in both groups. The risk reducing effect of smoking is followed by a rebound phenomenon after giving up smoking. This occurs mainly in heavy smokers who have a more than four-fold increased risk to develop UC. No sex difference was found. The finding of an increased risk in former smokers is in accordance with the reevaluated results of Logan et all' and also the observation by Benoni and Nilsson."`They found a male dominance of such patients, however, which we could not confirm. This is the first study where a significance of earlier daily cigarette consumption has been shown as a risk factor in a dose dependent way. It is further worth noting the long period many patients had been former smokers before developing UC.
The findings in the CD group were contrary to those in UC. Smoking doubled the risk of acquiring CD and there did not seem to exist a dose dependent effect. There were no sex differences. That smoking is more prevalent in patients with CD than in controls both at the time of diagnosis and later during the course of the disease is in accordance with earlier results.6`This is mainly because of the low proportion of never smokers in patients with CD. 
Addendum
After preparation of the manuscript two further studies on UC have been published. In spite of a low response rate (85% in patients and 62% in control subjects) Boyko et al'9 found relative risks very similar to those found by us in current or former smokers. Also the median time of six years or slightly more that elapsed before former smokers developed UC was similar to our finding. In another study2' the mean time was found to be 5-7 years. disease. A case control study. 
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